AI in Drug Discovery with Dr. Urban Kiernan

In this insightful episode of The DNA of Things, host Dr. Jeremy Koenig sits down with Dr. Urban Kiernan, the visionary founder, chairman, and CEO of iMetabolic Biopharma, to explore the future of personalized healthcare and drug discovery. Dr. Kiernan, with a robust background in bioanalytical chemistry and proteomics, shares his inspiring journey from academia to the biotech industry, spurred by personal tragedy and a deep commitment to improving cardiovascular health. The discussion delves into cutting-edge topics such as the potential of lipid metabolism in treating diseases, the role of bioinformatics, and his innovative "tech bio" approach, which integrates AI in drug discovery to make healthcare more accessible and affordable. Dr. Kiernan also highlights the high costs and challenges of drug development while stressing the critical importance of resilience, personal health, and societal changes in addressing global health issues like obesity. This episode is a must-listen for healthcare professionals, biotech enthusiasts, and anyone fascinated by the future of medicine and personalized healthcare innovations.
Episode Highlights:
Personalized healthcare and bioinformatics
Lipid metabolism and disease treatment
Dr. Urban Kiernan's career transition and personal tragedy
Founding of iMetabolic Biopharma
AI-driven drug discovery platforms
Challenges and costs in cardiovascular disease treatment
The future of drug development and healthcare innovation
Global health issues and the role of personal health
Connect with Dr. Urban Kiernan
LINKS:
www.drjeremyko...
/ drjeremykoenig
/ @drjeremykoenig